Dr. Mark Jack Der Mesropian, DO

Dr. Der Mesropian practices at Monmouth Medical Center in Long Branch, New Jersey, part of RWJBarnabas Health.

Dr. Der Mesropian's NPI, 1124309349, was assigned on September 1, 2011. Dr. Der Mesropian holds New Jersey license 25MB10061600.

Dr. Der Mesropian's primary practice is Monmouth Medical Center, at 300 Second Avenue, Long Branch, NJ 07740 in Monmouth County. The practice phone is (732) 222-5200.

Dr. Der Mesropian's primary practice is Monmouth Medical Center in Long Branch, New Jersey, part of RWJBarnabas Health. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Der Mesropian to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Der Mesropian practices. Vendor and product names are available with a free account.

Anesthesiology is Dr. Der Mesropian's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Der Mesropian is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Der Mesropian's licenses on file in 2 states: New Jersey and Connecticut.

CMS data shows 39 Medicare services from Dr. Der Mesropian across 2 procedure codes in 2024, for 161 Medicare patients. Medicare paid $5,302 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 161 Medicare patients who saw Dr. Der Mesropian in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Der Mesropian's median patient age at 38, with 84% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Der Mesropian for performance year 2024, reported as part of a group. Dr. Der Mesropian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Der Mesropian from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Eagle Pharmaceuticals, Inc. paid the most, $28.